The rising prevalence in GLP-1 agonists for metabolic health has sparked a question about formats: skin-applied devices versus pills . Traditionally , GLP-1 therapies were exclusively available in pill https://maertkh990008.wizzardsblog.com/40918125/glp-1-skin-applications-vs-oral-medications-what-best-for-the-patient